Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
---|---|---|---|---|---|---|---|---|
ELECTRON TRANSPORT CHAIN | affect | 170 | ||||||
ELECTRON TRANSPORT CHAIN | 0.56 mol/mol F1 | bovine | heart MF1-ATPase | decrease | IC50 | 134 | ||
ELECTRON TRANSPORT CHAIN | 70 ng/ml | C. asciculate | MF1-ATPase | decrease | IC50 | 135 | ||
ELECTRON TRANSPORT CHAIN | 0.3 μM | human | umbilical vein endothelial cell, nonmitochondrial ATP synthase | decrease | IC50 | 136 | ||
ELECTRON TRANSPORT CHAIN | 0.5 μg/ml | R. rubrum | chromatophores | decrease | IC50 | 137 | ||
ELECTRON TRANSPORT CHAIN | 0.05-0.5 μg of inhibitor/mg protein | T. pyriformis | SMP-ATPase | decrease | IC50 | 138 | ||
ELECTRON TRANSPORT CHAIN | 21.5 μM | EF1-ATPase | decrease | ki | 139 | |||
ELECTRON TRANSPORT CHAIN | 10 nM | bovine | heart MF1-ATPase | decrease | kd | 134 | ||
ELECTRON TRANSPORT CHAIN | 2.4 mol inhibitor/mol enzyme | bovine | heart SMP-ATPase | decrease | complete inhibition | 134 | ||
Target | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
---|---|---|---|---|---|---|---|---|
ATP synthase | 0.56 mol/mol F1 | bovine | heart MF1-ATPase | inhibitor | IC50 | 134 | ||
ATP synthase | 70 ng/ml | C. asciculate | MF1-ATPase | inhibitor | IC50 | 135 | ||
ATP synthase | 0.3 μM | human | umbilical vein endothelial cell, nonmitochondrial ATP synthase | inhibitor | IC50 | 136 | ||
ATP synthase | 0.5 μg/ml | R. rubrum | chromatophores | inhibitor | IC50 | 137 | ||
ATP synthase | 0.05-0.5 μg of inhibitor/mg protein | T. pyriformis | SMP-ATPase | inhibitor | IC50 | 138 | ||
ATP synthase | 21.5 μM | EF1-ATPase | inhibitor | ki | 139 | |||
ATP synthase | 10 nM | bovine | heart MF1-ATPase | inhibitor | kd | 134 | ||
ATP synthase | 2.4 mol inhibitor/mol enzyme | bovine | heart SMP-ATPase | inhibitor | complete inhibition | 134 | ||
F1 subunits | inhibitor | 170 | ||||||